Skip to content
OpenCapital
Get started

NuSkin Enterprises NUS Cash & Equivalents

Cash & Equivalents at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$87.58M+1.3%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
$12.48M-44.4%
USANA Health Sciences logo
USANA Health SciencesUSNA
$165.66M-9.2%
Estee Lauder Companies Inc. logo
Estee Lauder Companies Inc.EL
$3.13B+18.8%
Herbalife logo
HerbalifeHLF
$451.2M+37.0%
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
$573K-68.5%

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-34.9%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's cash & equivalents?
NuSkin Enterprises (NUS) reported cash & equivalents of $198.65M in Q1 2026.
How has NuSkin Enterprises's cash & equivalents changed year-over-year?
NuSkin Enterprises's cash & equivalents decreased by 2.5% year-over-year, from $203.77M to $198.65M.
What is the long-term trend for NuSkin Enterprises's cash & equivalents?
Over 5 years (2020 to 2025), NuSkin Enterprises's cash & equivalents has grown at a -9.9% compound annual growth rate (CAGR), from $402.68M to $238.63M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.